HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/18/2012 -- Hovnanian Enterprises, Inc. (NYSE:HOV) shares have gained over 50 percent in the last three months as the company continues to benefit from the U.S. Housing market's recovery. The Commerce Department on Wednesday reported that home construction is currently at a four-year high. Hovnanian Enterprises, Inc.(NYSE:HOV) shares climbed 9.79% to $4.15 in the early hour. Hovnanian’s stock was upgraded by MKM Partners from a “sell” rating to a “neutral” rating in a research note issued last month. Additionally, the company, this month, announced that the early tender period in respect of the previously announced cash tender offer and consent solicitation by its wholly owned subsidiary, K. Hovnanian Enterprises, Inc., for any and all of K. Hovnanian’s outstanding 10 5/8% Senior Secured Notes Due 2016 expired on October 1, 2012 at 5:00 p.m., New York City time.
Can HOV Continue Rally From Here Or Going Down : CLICK HERE To Know More
Dean Foods Company (NYSE:DF) is very active today and traded between $16.87 - 18.23 with total traded volume of 6541418 shares. At a current price of 17.90, DF is +0.94 - +5.54% from the previous close of $16.96. Moreover, At Current Market Price, DF is in the distance of +12.17% from its 50-day Moving Average price of $15.9574 and +21.49% from its 200-day Moving Average price of $14.734. Dean Foods Company(NYSE:DF) stock gained 12.77% to $16.96 in the previous trading session after Dean Foods Co unit Whitewave Foods Co said it plans to raise up to $320 million in an initial public offering. The company would offer 20 million Class A common shares for between $14 and $16 per share. In August, Dairy company Dean Foods announced plans to sell 20% of WhiteWave Foods Co in an IPO. Additionally, Stifel Nicolaus upgraded shares of Dean Foods from a hold rating to a buy rating in a report issued last week. They currently have $18.00 target price on the stock.
Should Investor Invest Money In DF Or Wait: CLICK HERE
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat lipid disorders. As of December 31, 2011, the Company developed its first product candidate, lomitapide, as an oral, once-a-day treatment for patients with a inherited lipid disorder called homozygous familial hypercholesterolemia. Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) announced after the bell Wednesday that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA determined by a vote of 13 to 2 that Aegerion has presented sufficient safety and efficacy data to support marketing of lomitapide, for the treatment of patients with Homozygous Familial Hypercholesterolemia. Aegerion Pharmaceuticals (NASDAQ:AEGR) gapped open higher Thursday and has continued to gain ground in early trade. Shares are now up 2.65 at $21.80 on above average volume. The stock has climbed to its third consecutive new high for the year.
Should Investors Buy AGER Now? Find out here
Travelers Companies Inc. (NYSE:TRV) is +2.705 - +3.79% from the previous close of $71.38. It traded between $73.21 - 74.70 with total traded volume of 3006351 shares. Keep a close eye on TRV, as the stock has been showing unusual moves over the past weeks. At Current market price, TRV has recovered +41.09% from its 52-week Low of 52.51 and has Pulled back +3.79% from its 52-week high of 71.38. Travelers Companies Inc. (NYSE: TRV) reported a surge in quarterly earnings, helped by lower catastrophe losses and higher underlying underwriting results. Travelers Companies, Inc. (NYSE: TRV) is scheduled to report third-quarter results. The company is expected to post earnings of $1.61 per share, higher than the year-ago quarter's $0.79 per share. Also, the company is anticipated to generate revenues of $5.79 billion compared to $5.67 billion in the prior-year quarter. The company's shares closed Wednesday's session at $71.38.
Can TRV Recover Further ? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)